BACKGROUND: Noroviruses are the leading cause of acute gastroenteritis outbreaks worldwide. Clarifying the viral, host, and environmental factors (epidemiologic triad) associated with severe outcomes can help target public health interventions. METHODS: Acute norovirus outbreaks reported to the National Outbreak Reporting System (NORS) in 2009-2016 were linked to laboratory-confirmed norovirus outbreaks reported to CaliciNet. Outbreaks were analyzed for differences in genotype (GII.4 vs non-GII.4), hospitalization, and mortality rates by timing, setting, transmission mode, demographics, clinical symptoms, and health outcomes. RESULTS: A total of 3747 norovirus outbreaks were matched from NORS and CaliciNet. Multivariable models showed that GII.4 outbreaks (n = 2353) were associated with healthcare settings (odds ratio [OR], 3.94 [95% confidence interval {CI}, 2.99-5.23]), winter months (November-April; 1.55 [95% CI, 1.24-1.93]), and older age of cases (≥50% aged ≥75 years; 1.37 [95% CI, 1.04-1.79]). Severe outcomes were more likely among GII.4 outbreaks (hospitalization rate ratio [RR], 1.54 [95% CI, 1.23-1.96]; mortality RR, 2.77 [95% CI, 1.04-5.78]). Outbreaks in healthcare settings were also associated with higher hospitalization (RR, 3.22 [95% CI, 2.34-4.44]) and mortality rates (RR, 5.65 [95% CI, 1.92-18.70]). CONCLUSIONS: Severe outcomes more frequently occurred in norovirus outbreaks caused by GII.4 and those in healthcare settings. These results should help guide preventive interventions for targeted populations, including vaccine development. Published by Oxford University Press for the Infectious Diseases Society of America 2018.
BACKGROUND: Noroviruses are the leading cause of acute gastroenteritis outbreaks worldwide. Clarifying the viral, host, and environmental factors (epidemiologic triad) associated with severe outcomes can help target public health interventions. METHODS: Acute norovirus outbreaks reported to the National Outbreak Reporting System (NORS) in 2009-2016 were linked to laboratory-confirmed norovirus outbreaks reported to CaliciNet. Outbreaks were analyzed for differences in genotype (GII.4 vs non-GII.4), hospitalization, and mortality rates by timing, setting, transmission mode, demographics, clinical symptoms, and health outcomes. RESULTS: A total of 3747 norovirus outbreaks were matched from NORS and CaliciNet. Multivariable models showed that GII.4 outbreaks (n = 2353) were associated with healthcare settings (odds ratio [OR], 3.94 [95% confidence interval {CI}, 2.99-5.23]), winter months (November-April; 1.55 [95% CI, 1.24-1.93]), and older age of cases (≥50% aged ≥75 years; 1.37 [95% CI, 1.04-1.79]). Severe outcomes were more likely among GII.4 outbreaks (hospitalization rate ratio [RR], 1.54 [95% CI, 1.23-1.96]; mortality RR, 2.77 [95% CI, 1.04-5.78]). Outbreaks in healthcare settings were also associated with higher hospitalization (RR, 3.22 [95% CI, 2.34-4.44]) and mortality rates (RR, 5.65 [95% CI, 1.92-18.70]). CONCLUSIONS: Severe outcomes more frequently occurred in norovirus outbreaks caused by GII.4 and those in healthcare settings. These results should help guide preventive interventions for targeted populations, including vaccine development. Published by Oxford University Press for the Infectious Diseases Society of America 2018.
Authors: Jennifer L Cannon; Leslie Barclay; Nikail R Collins; Mary E Wikswo; Christina J Castro; Laura Cristal Magaña; Nicole Gregoricus; Rachel L Marine; Preeti Chhabra; Jan Vinjé Journal: J Clin Microbiol Date: 2017-05-10 Impact factor: 5.948
Authors: Eyal Leshem; Mary Wikswo; Leslie Barclay; Eric Brandt; William Storm; Ellen Salehi; Traci DeSalvo; Tim Davis; Amy Saupe; Ginette Dobbins; Hillary A Booth; Christianne Biggs; Katie Garman; Amy M Woron; Umesh D Parashar; Jan Vinjé; Aron J Hall Journal: Emerg Infect Dis Date: 2013-08 Impact factor: 6.883
Authors: Laura E Calderwood; Mary E Wikswo; Claire P Mattison; Anita K Kambhampati; Neha Balachandran; Jan Vinjé; Leslie Barclay; Aron J Hall; Umesh Parashar; Sara A Mirza Journal: Clin Infect Dis Date: 2022-01-07 Impact factor: 9.079
Authors: Mia C Mattioli; Katharine M Benedict; Jennifer Murphy; Amy Kahler; Kelly E Kline; Allison Longenberger; Patrick K Mitchell; Sharon Watkins; Philip Berger; Orin C Shanks; Catherine E Barrett; Leslie Barclay; Aron J Hall; Vincent Hill; Andre Weltman Journal: J Microbiol Methods Date: 2020-10-31 Impact factor: 2.622
Authors: Molly K Steele; Mary E Wikswo; Aron J Hall; Katia Koelle; Andreas Handel; Karen Levy; Lance A Waller; Ben A Lopman Journal: Emerg Infect Dis Date: 2020-08 Impact factor: 6.883
Authors: Yaoska Reyes; Fredman González; Lester Gutiérrez; Patricia Blandón; Edwing Centeno; Omar Zepeda; Christian Toval-Ruíz; Lisa C Lindesmith; Ralph S Baric; Nadja Vielot; Marta Diez-Valcarce; Jan Vinjé; Lennart Svensson; Sylvia Becker-Dreps; Johan Nordgren; Filemón Bucardo Journal: J Infect Dis Date: 2022-01-05 Impact factor: 7.759